Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.4 USD | +0.07% | +0.07% | +358.59% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
Official Publications
- Stock Market
- Equities
- JNJ Stock
- 0R34 Stock
- News Johnson & Johnson
- Official Publications